89bio Inc. (ETNB) Mentioned Positively at RBC Capital on Akero (AKRO) Read Through
Tweet Send to a Friend
RBC Capital analyst Brian Abrahams reiterated an Outperform rating and $35.00 price target on 89bio Inc. (NASDAQ: ETNB).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
